Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0000899243-17-027619

Chairman sold 47,983 shares at an average $41.88 ($2,009,325)

  • Chairman acquired 47,983 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

El-Hibri Fuad · Chairman

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2017-11-28 Exercise or conversion : show line 1 in the form +20,000 $22.03 $440,600 1,550,216 D
2017-11-28 Sale : show line 2 in the form −20,000 $41.59 $831,800 1,530,216 D
2017-11-29 Exercise or conversion : show line 3 in the form +27,983 $22.03 $616,465 1,558,199 D
2017-11-29 Sale : show line 4 in the form −27,983 $42.08 $1,177,525 1,530,216 D
Open-market sales · 47,983 sh · avg $41.88 · $2,009,325

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2017-11-28 Exercise or conversion : show line 5 in the form Employee Stock Options (Right to Buy) −20,000 27,983 D
2017-11-29 Exercise or conversion : show line 6 in the form Employee Stock Options (Right to Buy) −27,983 0 D
Loading xslF345X03/doc4.xml…